Southside Bancshares Q4 Earnings, Revenue Rise-March 2024-www.financetom.com

Southside Bancshares Q4 Earnings, Revenue Rise

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Southside Bancshares Q4 Earnings, Revenue Rise

Jan 29, 2025 3:31 AM

06:03 AM EST, 01/29/2025 (MT Newswires) -- Southside Bancshares ( SBSI ) reported Q4 earnings Wednesday of $0.71 per diluted share, up from $0.57 a year earlier.

Four analysts polled by FactSet expected $0.72.

Revenue, expressed as the sum of net interest income and noninterest income, was $66 million for the quarter ended Dec. 31, up from $57 million.

Four analysts surveyed by FactSet expected $68.1 million.

Previous page： Analog Devices Insider Sold Shares Worth $2,663,640, According to a Recent SEC Filing Next page： CRISPR Therapeutics COO to Step Down

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Analog Devices Insider Sold Shares Worth $2,663,640, According to a Recent SEC Filing

Mar 26, 2025

04:42 PM EDT, 03/26/2025 (MT Newswires) -- Vivek Jain, Executive Vice President, Global Operations, on March 24, 2025, sold 12,684 shares in Analog Devices ( ADI ) for $2,663,640. Following the Form 4 filing with the SEC, Jain has control over a total of 43,175 common shares of the company, with 43,175 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/6281/000000628125000088/xslF345X05/wk-form4_1743021114.xml ...

CRISPR Therapeutics COO to Step Down

Mar 26, 2025

04:38 PM EDT, 03/26/2025 (MT Newswires) -- CRISPR Therapeutics ( CRSP ) said late Wednesday that Chief Operating Officer Julianne Bruno will be stepping down from the company to pursue external opportunities, effective April 11. ...

US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports

Mar 26, 2025

March 26 (Reuters) - Federal prosecutors in Manhattan are probing a claim brought by GSK that Pfizer ( PFE ) delayed announcing the success of its COVID-19 vaccine in 2020 until after that year's election, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. ...

Jefferies Financial Fiscal Q1 Earnings, Revenue Decline; Quarterly Dividend Unchanged -- Shares Down After Hours

Mar 26, 2025

04:36 PM EDT, 03/26/2025 (MT Newswires) -- Jefferies Financial ( JEF ) reported fiscal Q1 earnings late Wednesday of $0.57 per diluted share, compared with $0.66 a year earlier. Four analysts polled by FactSet expected $0.94. Net revenue for the quarter ended Feb. 28 was $1.59 billion, compared with $1.74 billion a year earlier. Three analysts polled by FactSet expected...